Focusing on the humoral response to SARS-CoV-2 infection in a cohort of 88 COVID-19 patients, we found that anti-SARS-CoV-2 RBD IgA was the dominant isotype in the serum of these patients during the infection, with 52.3% showing IgA-dominant COVID-19. This evidence concerns the gene CD79A and COVID-19.